All manuscripts
Publications CTL Cells G-Rex®10 G-Rex®100

SOP: D03.32.21 EXPANSION OF EBV- OR ANTIGEN-SPECIFIC CYTOTOXIC T LYMPHOCYTES (CTL)

Published

Share
11 pages SOP: D03.32.21 EXPANSION OF EBV- OR ANTIGEN-SPECIFIC CYTOTOXIC T LYMPHOCYTES (CTL) — 2011

Overview

SOP for expanding CTLs. Detailed instructions for using G-Rex®40 and G-Rex®500. Describes transfer of cells to G-Rex®, adding media and IL-2, feeding schedules (removing half media), and splitting cells if density is high

What this paper found

This standard operating procedure from a Houston GMP facility describes how to expand EBV-specific and antigen-specific cytotoxic T lymphocytes to meet patient dose, quality-control and research needs. T cells are restimulated with irradiated autologous lymphoblastoid cell lines, in either 24-well plates or GRex flasks. In GRex flasks, responder cells are resuspended at 1 × 10^6 cells per mL and combined with LCLs at a 5:1 ratio, with IL-2 at 50 to 100 units per mL. Cells with viability above 60% proceed directly; otherwise dead cells are removed on Lymphoprep gradients. Cultures can be expanded in the bioreactor for up to 16 to 18 days. Expected results are sufficient CTL numbers for infusion and under 2% CD19+ B cells by flow cytometry, which excludes residual LCL.

Since all cells prepared are intended for infusion to patients, it is essential to adhere to proper procedures to prevent misidentification or contamination of patient samples. — Cliona Rooney, Oumar Diouf, Malcolm Brenner, Adrian Gee

Study details

Authors
Cliona Rooney, Oumar Diouf, Malcolm Brenner, Adrian Gee
Institution
Center for Cell & Gene Therapy, GMP Facility, Houston, Texas
Year
2011
G-Rex® model(s)
G-Rex®10, G-Rex®100
Cell type(s)
CTL Cells
Application area
Hematologic malignancy · Infectious disease

How G-Rex® was used

CTLs are restimulated in GRex flasks from the second stimulation, using autologous irradiated LCLs at a 5:1 ratio of LCLs to CTLs. Responder cells are resuspended at 1 × 10^6 cells per mL, GRex40 receives 5 × 10^6 LCLs in 30 mL, and GRex500 receives 5 × 10^7 LCLs in 200 mL. IL-2 at 50 to 100 units per mL is given, and about half the medium is replaced at feeds every 3 to 4 days. Flasks above 50 × 10^6 cells (GRex40) or 500 × 10^6 cells (GRex500) are split 1:1, and cultures can run for 16 to 18 days.

Explore related

Building a similar workflow?

Talk to a ScaleReady specialist about how the G-Rex® platform can support your program — from process development to clinical-scale manufacturing.

Start a conversation →